Beclometasone hydrofluoroalkane intranasal - Teva

Drug Profile

Beclometasone hydrofluoroalkane intranasal - Teva

Alternative Names: BDP HFA Nasal Aerosol; Beclometasone HFA intranasal - Teva; Beclomethasone HFA intranasal - Teva; Beclomethasone hydrofluoroalkane intranasal - Teva; Qnasl; Qnaze™

Latest Information Update: 02 Mar 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Perennial allergic rhinitis; Seasonal allergic rhinitis

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 19 Dec 2014 Registered for Seasonal allergic rhinitis and Perennial allergic rhinitis (In children) in USA (Intranasal)
  • 07 Nov 2014 Efficacy & adverse events data from a phase III trial in Perennial allergic rhinitis (in children aged 4-11 years) presented at the 71st Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI-2014)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top